Transplant Nephrologist @ Mayo Clinic Arizona
Director - Kidney Transplant Program (Deceased Donor)
Tac/mTOR/pred regimen VS tac/MMF/pred regimen in older kidney txp recipients
📌 did not affect graft outcomes
📌 did not increase risk of rejection
📌 did not affect risk of CMV, BK, or skin cancers
📌 more side effects
journals.lww.com/jasn/fulltex...
Tac/mTOR/pred regimen VS tac/MMF/pred regimen in older kidney txp recipients
📌 did not affect graft outcomes
📌 did not increase risk of rejection
📌 did not affect risk of CMV, BK, or skin cancers
📌 more side effects
journals.lww.com/jasn/fulltex...